Can STP answer the avian flu threat?

Remote trading is becoming an increasingly viable straight-through processing proposition for those firms looking to limit the damage a potential outbreak of human-to-human avian flu could cause. By Choongo Moonga

AS the threat of human-to-human transmission of the Avian flu virus gathers pace, banks and broker-dealers are paying more attention to the potential impact an outbreak could have on the trade-processing chain.

As of mid-January, the virus has killed 79 people in east Asia and Turkey, as the threat continues to move towards mainland Europe. As a result, European and Asian financial institutions are more concerned about the immediate impact of the flu than their US counterparts. Fortis, the Dutch

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here